Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure

CARDIOVASCULAR EFFECTS OF ORAL ANTIVIRAL TREATMENT FOR NON-CARDIAC HCV PATIENTS

Hematological Effects of Antiviral Drugs for Hepatitis C Virus

Effect of Direct Acting Anti-viral Agents on Insulin Resistance in Chronic HCV Patients

Effect of Treating Chronic Hepatitis C Infection with Direct-Acting Antivirals on The Risk of Recurrence Hepatocellular Carcinoma

Effect of Treatment of Hepatitis C by Directly Acting Antivirals (DAA) on Chronic Hepatitis C, B Coinfected Patients

A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs

EFFECT OF HCV DIRECT ANTIVIRAL AGENTS ON PORTAL CIRCULATION HEMODYNAMICS IN CIRRHOTIC PATIENTS

Direct Acting Anti-Viral Therapy, and Potential Increase in the Incidence of Hepato-Cellular Carcinoma in Cirrhotic Patients With Hepatitis C Virus

Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients